We are delighted to announce that Cambridge Bioscience has partnered with Virax Biolabs, a company specialising in innovative solutions for detecting immune responses and diagnosing viral infections. With a unique focus on T-cell-based testing technologies, Virax Biolabs aims to develop a comprehensive immunology profiling platform that supports diagnostics and treatment strategies, especially for post-viral syndromes.
The ImmuneSelect portfolio from Virax Biolabs offers an extensive selection of peptide pools designed to stimulate T cells with epitopes specific to various pathogens. ImmuneSelect also provides Recombinant Antibodies aimed at cytokines and biomarkers, available in unconjugated forms suitable for a range of applications like Flow Cytometry, ELISA, and ELISpot/Fluorospot assays. With user-friendly design and compatibility with standard lab equipment, ImmuneSelect delivers accessible, affordable tools for diverse research needs.
Cambridge Bioscience are pleased to distribute Virax Biolabs products in the UK and Ireland.
Learn more about Virax Biolabs or contact our Virax Biolabs specialists.